Volume 2, Issue 8 (Autumn 1999)
J Arak Uni Med Sci 1999, 2(8): 10-14 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zarganj Fard, Hashemi P, Falahian M. The Study of Effectiveness and Side Effects of Injectable Progestrones On Contraceptive in Imam Hossein Hospital of Tehran. J Arak Uni Med Sci 1999; 2 (8) :10-14
URL: http://jams.arakmu.ac.ir/article-1-6589-en.html
URL: http://jams.arakmu.ac.ir/article-1-6589-en.html
1- School of Medicine, Arak University of Medical Sciences, Arak, Iran.
2- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract: (804 Views)
One of the most critical problems in the world is control of population. Usage of DMPA (Depo Medroxy Progestrone Acetate) is one effective method for contraception. This study was done on 55 patients in Imam Hossein Hospital of Tehran. The interval of injections of DMPA were 3 months and the dosage of this hormone was 150 grams; In this research the side effect of DMPA on the compliance of patients the cause of discontinuation of DMPA were assessed. 18 number of patients has received 4 and 17 number of them had received only 1 injection. The age of majority of them were over 30 years and 34 of them had one or two children. 88% of these women had menstrural abnormalities and the most problem was amenorrhea. The majority of women in this study had weight gain ( mean 6.9Kg). Hypertension was not side effect of DMPA. The most common complaints of our patients were menstrural abnormalities, headache and nervousness. The most common cause of discontinuation of DMPA was menstrural problems especially amenorrhea. One case of pregnancy has occurred between 55 patients in this study.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
